Pharmaceutical composition for promoting cancer immunotherapy and method for promoting cancer immunotherapy

Abstract

A pharmaceutical composition for promoting a cancer immunotherapy and a method for promoting a cancer immunotherapy are provided. The pharmaceutical composition includes an uncoupling protein 2 inhibitor and an interleukin-17 blockade. The method includes administering an effective concentration of a pharmaceutical composition to a subject in need thereof, in which the pharmaceutical composition includes an uncoupling protein 2 inhibitor and an interleukin-17 blockade.

Dependencies are inferred from the claim text.